Advanced Search
Qin ShuKui, . Bonefos and 153Sm-EDTMP in the treatment of metastatic bone cancer[J]. Cancer Research on Prevention and Treatment, 1995, 22(1): 25-27.
Citation: Qin ShuKui, . Bonefos and 153Sm-EDTMP in the treatment of metastatic bone cancer[J]. Cancer Research on Prevention and Treatment, 1995, 22(1): 25-27.

Bonefos and 153Sm-EDTMP in the treatment of metastatic bone cancer

More Information
  • This paper dealt with the treatment of 74 cases of metastatic bone cancer with Bonefos and /or 153Sm-EDTMP intraradiation. 21 cases treated with Bonefos and 26 cases treated with 153Sm-EDTMP.the total remission rates of the bone pain were respectively 85. 7% and 80. 8%, and the to-tal effective rates of the bone lesion were respectively 9. 5% and 19. 2 % . 31 cases treated with the combination 13onefos with 153Sm-EDTh1P, the two rates before mentioned were respectively 93. 5 % and 45. 2% which was signi-ficantly better than the above results (<0. 05). The side effects were ruse. These results showed that Bonefos plus 153Sm-EDTWP are the effective and safe therapy,may be the better treatment of choice against metastaitc multiple bone carcinoma.
  • [1]
    林伟翰著.肿瘤诊疗疑难析福建科技出版社.1987. 66-73页
    [2]
    Martoni A, Guaraldi M, Camera D. et al. Controlled clinical study on the use of Bonefos in patients with breast carcinoma metastasizing to the skeleton. Oncol-gy.1991,48:97-101
    [3]
    蒋长英、朱蓓玲、章英剑,等.153Sm-EDTMP对癌症骨痛治疗和提高生活质量的价值.中华肿瘤杂志.1994.16(2):118-120
    [4]
    W HO癌治疗结果报告的标准.中华肿庙杂志.1982.4(4):311-314

Catalog

    Article views (1588) PDF downloads (273) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return